CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Quick Ratio

OXGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




OXGN Quick Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Current Liabilities Change 225.75 % 302.12 % 759.59 % 373.35 % 87.61 %
Y / Y Cash & cash equivalent Change 8305.45 % 684.25 % -82.66 % -95.83 % -93.04 %
Quick Ratio MRQ 0.16 0.08 0.02 0.01 0.01
Overall Ranking # # # # #
Seq. Current Liabilities Change 6.66 % -3.16 % 25.08 % 152.13 % 31.67 %
Seq. Cash & cash equivalent Change 106.11 % 260.29 % 123.8 % 405.76 % -80.77 %



Quick Ratio third quarter 2020 Comment
Mateon Therapeutics Inc's Cash & cash equivalent grew by 106.11 % in III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Mateon Therapeutics Inc's Quick Ratio to 0.16, Quick Ratio remained below Mateon Therapeutics Inc average.

Within Biotechnology & Drugs industry 197 other companies have achieved higher Quick Ratio than Mateon Therapeutics Inc in third quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are OXGN Segments?
See Quick Ratio OXGN on the trailing twelve month basis
Quick Ratio third quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 198
Healthcare Sector # 773
Overall Market # 3430


Quick Ratio Statistics
High Average Low
44.39 10.52 0.01
(Mar 31 2015)   (Sep 30 2019)




Financial Statements
Mateon Therapeutics Inc's Current Liabilities $ 9 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Cash & cash equivalent $ 1 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2020, within Biotechnology & Drugs Industry Quick RatioSep 30 2020 MRQ Cash & cash equivalentSep 30 2020 MRQ Current Liabilities
Regenerx Biopharmaceuticals Inc  0.40 $ 0.139  Millions$ 0.345  Millions
Quidel Corporation  0.37 $ 77.547  Millions$ 207.886  Millions
Amyris Inc   0.37 $ 38.280  Millions$ 103.581  Millions
Biogen Inc   0.36 $ 1,355.000  Millions$ 3,804.000  Millions
Nexien Biopharma Inc   0.33 $ 0.008  Millions$ 0.025  Millions
Abbvie Inc   0.33 $ 7,950.000  Millions$ 24,181.000  Millions
Intelgenx Technologies Corp   0.33 $ 1.531  Millions$ 4.667  Millions
Avantor Inc   0.33 $ 370.500  Millions$ 1,136.000  Millions
Protalix Biotherapeutics inc   0.31 $ 13.533  Millions$ 43.895  Millions
Cell Medx Corp   0.28 $ 0.120  Millions$ 0.423  Millions
Cytodyn Inc   0.24 $ 18.200  Millions$ 76.424  Millions
Conversion Labs Inc   0.22 $ 2.010  Millions$ 9.023  Millions
Predictive Oncology Inc   0.21 $ 2.474  Millions$ 11.607  Millions
Iterum Therapeutics Plc  0.21 $ 8.570  Millions$ 40.792  Millions
Cure Pharmaceutical Holding Corp   0.21 $ 1.102  Millions$ 5.317  Millions
Amarillo Biosciences Inc  0.19 $ 0.084  Millions$ 0.445  Millions
Mateon Therapeutics Inc  0.16 $ 1.362  Millions$ 8.764  Millions
Therapeutic Solutions International Inc   0.14 $ 0.284  Millions$ 1.966  Millions
Guided Therapeutics Inc  0.13 $ 1.074  Millions$ 8.305  Millions
Qrons Inc   0.12 $ 0.092  Millions$ 0.793  Millions
Nascent Biotech Inc   0.11 $ 0.099  Millions$ 0.910  Millions
Inhibitor Therapeutics Inc   0.08 $ 0.037  Millions$ 0.459  Millions
Petvivo Holdings Inc   0.08 $ 0.175  Millions$ 2.272  Millions
Gtx Corp  0.07 $ 0.232  Millions$ 3.179  Millions
American Cryostem Corp  0.05 $ 0.055  Millions$ 1.050  Millions
Mitesco Inc   0.04 $ 0.102  Millions$ 2.721  Millions
Cannapharmarx Inc   0.03 $ 0.243  Millions$ 7.789  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CERS's Profile

Stock Price

CERS's Financials

Business Description

Fundamentals

Charts & Quotes

CERS's News

Suppliers

CERS's Competitors

Customers & Markets

Economic Indicators

CERS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071